stock surge

$BYND jumps 4.1% on meme stock momentum despite 19.7% sales decline, $0.29 loss per share, and weak 2.3% gross margin in Q4.

Sun Pharma agrees to acquire Organon for $14/share in all-cash deal, sending shares up 16.87% as women's health firm finds exit after struggling 2021 Merck spinoff.

Bed Bath & Beyond stock surged 25% after beating Q1 revenue estimates with $247.76 million in sales and achieving first growth quarter in 19 quarters amid stabilization efforts.

Oil-Dri director sells $102K in stock after 75% surge and record revenue, marking typical profit-taking amid margin pressures.

Aehr Test Systems founder offloads $1.77M in shares as stock soars 1,076% annually. Stretched valuation raises concerns despite strong AI semiconductor demand.

Beyond Meat stock rose 6.1% this week amid broader market gains and meme-stock activity, but faces structural challenges including collapsing sales and razor-thin margins.

Intel surged 23.5% on strong Q1 earnings, with data center revenue jumping 22%. The chipmaker is positioned as critical AI infrastructure player.

Intel surges 27.6% on Q1 earnings beat, with AI revenue reaching 60% of sales and growing 40% yearly, while Q2 guidance more than doubles analyst estimates.

Trump administration's $8.9B Intel investment surges to $35.4B as stock jumps 290% on AI demand and earnings beat.

Intel crushes Q1 earnings with $0.29 EPS versus $0.01 estimate, guides Q2 to $0.20 EPS. Stock jumps 14.85% on AI demand optimism.

Nuburu stock surged 20% after hours following insider disclosures of a $1.4M convertible note conversion and stock grants, raising shareholder dilution concerns.

Micron Technology jumped 8.5% to $487.57 on April 22, 2026, extending a six-month rally exceeding 145% amid robust AI-driven memory chip demand and Iran ceasefire developments.

Spirit Airlines stock surges 213% on Trump administration's proposed $500 million government loan, featuring warrant provisions to prevent the carrier's second bankruptcy.

Legend Biotech surges 18% on bullish analyst upgrades and momentum from Eli Lilly's $7B CAR-T acquisition, with CD19/CD20 therapy driving investor enthusiasm.

QuantumScape stock surged 10% this week, rebounding from year-to-date declines ahead of Q1 earnings on April 22, as investors anticipate updates on its Eagle Line pilot facility and Volkswagen partnership progress.

Iridium soared 22% after Amazon's $11B Globalstar acquisition reignited investor appetite for satellite communications, validating the sector's strategic importance.

Oracle stock soared 30% in one week, driven by $400M warrant gains, AI product launches, and a 2.8GW fuel-cell partnership with Bloom Energy.

Repay Holdings surges 28% on $4.80-per-share acquisition proposal from Forager Capital, representing 75% premium to recent trading levels.

EOS Energy stock surged 26.5% following a power solutions partnership with TURBINE-X Energy targeting AI data centers, though analysts question if gains are justified given flat quarterly revenue.

Xanadu Quantum shares jumped 44% Thursday amid sector-wide quantum rally following Nvidia's Ising AI model launch and Xanadu's Aurora computer progress.